|
SCIENCE NEWS
Researchers Discover Brain-protecting Protein
Johns Hopkins researchers have discovered a novel protein that can protect brain cells by interrupting a naturally occurring "stress cascade" resulting in cell death. [Johns Hopkins University, Baltimore]
St. Jude Children's Research Hospital Scientists Discover a New Mechanism Controlling Neuronal Migration
The molecular machinery that helps brain cells migrate to their correct place in the developing brain has been identified by scientists at St. Jude Children's Research Hospital. [Department of Developmental Neurobiology, St.Jude's Children Hospital, Memphis]
Digital Rat Brain Spontaneously Develops Organized Neuron Patterns
Blue Brain, a computer designed to mimic a functioning slice of a rat's brain, initially fired its virtual neurons only when prodded by a simulated electrical current. But recently, that has changed. [École Polytechnique Fédérale de Lausanne, Lausanne]
Tension in Axons is Essential for Synaptic Signaling, Researchers Report
Researchers report that every time a neuron dump neurotransmitters into the synapse between the cells, they rely on a simple mechanical reality: Tension in the axon of the presynaptic neuron is required. [University of Illinois, Chicago]
Healthy Neurons Transplanted into Patients with Huntington's Disease Also Develop Disease-like Pathology
A recent study provides the first demonstration that transplanted cells fail to offer a long-term replacement for degenerating neurons in patients with Huntington's disease. [Université Laval, Quebec City]
Why Neural Stem Cells Divide and Differentiate
Researchers report that the secreted protein EGFL7 (Epidermal Growth Factor-like domain 7) is the previously unidentified soluble Notch inhibitor. [Goethe University, Frankfurt]
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
|
|
INDUSTRY NEWS
Connexon Creative Launches Cord Blood News
Cord Blood News is a weekly e-newsletter that keeps members of the cord blood community informed by providing the latest news from all areas of the field, including its science, research, policy, and business.
NIH Launches the Human Connectome Project to Unravel the Brain's Connections
The National Institutes of Health Blueprint for Neuroscience Research is launching a $30 million project that will use cutting-edge brain imaging technologies to map the circuitry of the healthy adult human brain.
ImmunoCellular Therapeutics Retains Services of Torrey Pines Institute for Molecular Studies and Renowned Immunologist to Evaluate Lead Product Candidate
ImmunoCellular Therapeutics, Ltd. announced recently that it has retained the services of the Torrey Pines Institute for Molecular Studies in San Diego, CA, to evaluate the immunogenicity of peptides to target cancer stem cells relating to the Company's lead product candidate ICT-121.
Yissum Licenses Stem Cell Technologies for Spinal Therapy to TheraCell, Inc.
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., recently announced that it has licensed a novel package of stem cell related technologies to TheraCell, Inc., which will further develop and commercialize the technology for advanced regenerative medicine procedures such as spinal fusion.
Spinal Cord Injury Research Focus of Bryon Riesch Paralysis Foundation Grant
Support from the Bryon Riesch Paralysis Foundation will allow a Medical College of Wisconsin faculty member to research whether neurally modified cells derived from human bone marrow can be used to repair damage caused during spinal cord injury.
Case Western Reserve University Receives $5M from Third Frontier Commission for the Center for Stem Cell and Regenerative Medicine
The Center for Stem Cell and Regenerative Medicine, comprised of Case Western Reserve University, Cleveland Clinic, University Hospitals, and Athersys, Inc. has received $5 million from Ohio's Third Frontier Commission under the Research Commercialization Program.
UK to Channel EUR $21M into Regenerative Medicine
The UK's Office for Life Sciences will invest EUR $21M into the development of stem cell therapies via its "Life Sciences Blueprint" program.
Canadian Biotechnology Feels the Pinch as Funds Dry Up
Canada will lose up to 7,000 high-skilled research and development jobs within one year if short-term financing cannot be obtained, results from the most recent BIOTECanada survey show
Cellular Dynamics International In-Licenses Key Patent Portfolio for Using Stem Cell-Derived Cells in Drug Testing
Cellular Dynamics International recently announced that it has exclusively in-licensed a US-issued patent portfolio on optimizing the stem cell differentiation selection process and on using heart cells in drug testing.
Cytori Expands Patent Protection for the Celution(R) System and Uses for Adipose Derived Stem and Regenerative Cells
Cytori Therapeutics, Inc. recently received a Notice of Allowance from the U.S. Patent and Trademark Office related to uses of the Celution(R) System for the treatment of bone related disorders.
|
|
|
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada |
|
|
